These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1690481)

  • 1. Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, Paraprost-controlled study.
    Yamaguchi O; Shiraiwa Y; Kobayashi M; Yokota T; Ohinata M; Aoki H; Tsuzuki T; Ohori M
    Urol Int; 1990; 45 Suppl 1():40-6. PubMed ID: 1690481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A double-blind trial on the effect of bunazosin hydrochloride for the symptoms of benign prostatic hypertrophy].
    Kumamoto Y; Tsukamoto T; Yachiku S; Kaneko S; Koyanagi T; Togashi M; Maru A; Tsuchida S; Nishizawa O; Orikasa S
    Hinyokika Kiyo; 1990 Oct; 36(10):1213-32. PubMed ID: 1702262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].
    Maekawa M; Kishimoto T; Yasumoto R; Wada S; Harada T; Ohara T; Okajima E; Hirao Y; Ohzono S; Shimada K
    Hinyokika Kiyo; 1990 Apr; 36(4):495-516. PubMed ID: 1696065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction.
    Chapple CR; Christmas TJ; Milroy EJ
    Urol Int; 1990; 45 Suppl 1():47-55. PubMed ID: 1690482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an alpha 1-adrenergic blocker (prazosin HCl) on micturition disturbances associated with benign prostatic hypertrophy.
    Shimizu K; Nakai K; Imai K; Yamanaka H
    Urol Int; 1990; 45 Suppl 1():36-9. PubMed ID: 1690479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prazosin in patients with benign prostatic obstruction.
    Hedlund H; Andersson KE; Ek A
    J Urol; 1983 Aug; 130(2):275-8. PubMed ID: 6192252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of prazosin HCl in the treatment of urinary flow obstruction due to prostatic hypertrophy.
    Kondo A; Gotoh M; Saito M; Takita T; Kobayashi M; Otani T; Ito K
    Urol Int; 1990; 45 Suppl 1():4-17. PubMed ID: 1690480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prazosin HCl on micturition disturbance associated with benign prostatic hypertrophy and bladder neck contracture.
    Kohama Y; Watanabe H; Sen Y; Yamamoto Y; Morioka M; Fujita Y
    Urol Int; 1990; 45 Suppl 1():26-9. PubMed ID: 1690477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prazosin HCl on the urethral pressure profile in patients with benign prostatic hyperplasia.
    Nakamura K; Kawashita E; Osumi Y; Usui T; Ishibe T
    Urol Int; 1990; 45 Suppl 1():30-5. PubMed ID: 1690478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effectiveness and safety of prazosin in the symptomatic treatment of benign prostatic hypertrophy].
    Jiménez Cruz JF; Server Pastor G; Rioja Sanz C; Salinas Casado J; Vela Navarrete R; Virseda Chamorro M
    Actas Urol Esp; 1990; 14(1):31-5. PubMed ID: 1692659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The conservative treatment of prostatic hypertrophy with Paraprost].
    Aito K; Watsubo E
    Hinyokika Kiyo; 1972 Jan; 18(1):41-4. PubMed ID: 4112552
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical studies on the effectiveness of prazosin HCl (Minipress tablets) in the treatment of dysuria accompanying benign prostatic hyperplasia.
    Aoki H; Ohninata M; Tsuzuki T; Ohhori M; Shiraiwa Y; Yamaguchi O; Kobayashi M; Yokota T; Numazato S; Sakuma S
    Urol Int; 1990; 45 Suppl 1():18-25. PubMed ID: 1690476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, double-blind, placebo-controlled trial of the efficacy of prazosin in the treatment of dysuria associated with benign prostatic hypertrophy.
    Le Duc A; Cariou G; Baron C; Cukier J; Quentel P; Faure G; Rambeaud JJ; Navratil H; Costa P; Richaud JJ
    Urol Int; 1990; 45 Suppl 1():56-62. PubMed ID: 1690483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of finasteride on invasive urodynamics and symptoms in the treatment of patients with bladder outflow obstruction due to benign prostatic hyperplasia.
    Tammela TL; Kontturi MJ
    J Urol; 1995 Oct; 154(4):1466-9. PubMed ID: 7544845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.
    Elhilali MM; Ramsey EW; Barkin J; Casey RW; Boake RC; Beland G; Fradet Y; Trachtenberg J; Orovan WL; Schick E; Klotz LH
    Urology; 1996 Mar; 47(3):335-42. PubMed ID: 8633398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and side-effects of prazosin as a symptomatic treatment of benign prostatic obstruction.
    Ruutu ML; Hansson E; Juusela HE; Permi JE; Rusk JI; Sotarauta MT; Talja MT; Wuokko EJ; Mattila MJ
    Scand J Urol Nephrol; 1991; 25(1):15-9. PubMed ID: 1710823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prazosin in men with symptoms of bladder neck obstruction and a non-hyperplastic prostate.
    Hedlund H; Andersson KE
    Scand J Urol Nephrol; 1989; 23(4):251-4. PubMed ID: 2480639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical overview of prazosin in the treatment of prostatic obstruction.
    Milroy E
    Urol Int; 1990; 45 Suppl 1():1-3. PubMed ID: 1690474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-week placebo-controlled double-blind study of prazosin in the treatment of prostatic obstruction due to benign prostatic hyperplasia.
    Chapple CR; Stott M; Abrams PH; Christmas TJ; Milroy EJ
    Br J Urol; 1992 Sep; 70(3):285-94. PubMed ID: 1384919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prazosin and carbachol in patients with benign prostatic obstruction.
    Hedlund H; Andersson KE
    Scand J Urol Nephrol; 1988; 22(1):19-22. PubMed ID: 2455331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.